keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Atrial natriuretic factor (1-28) from both human and porcine sources is a powerful suppressor of pro-opiomelanocortin (POMC) mRNA, while it only has a modest inhibition effect on βEP-LI release.
説明 | Atrial natriuretic factor (1-28) from both human and porcine sources is a powerful suppressor of pro-opiomelanocortin (POMC) mRNA, while it only has a modest inhibition effect on βEP-LI release. |
In vitro | ANF-(1-28) significantly enhances the levels of guanosine 3',5'-cyclic monophosphate (cGMP) from 1.3 +/- 0.3 to 106 +/- 22 pmol cGMP/10^6 cells, with a 50% effective dosage (ED 50) of 1.2 nM[1]. |
In vivo | The infusion of ANF-(1-28) at a dosage of 0.5 μg/kg/min significantly reduces the increase in plasma creatinine levels by about 50% daily throughout the study period[3]. |
別名 | Atrial natriuretic factor (1-28) (human, porcine), Atrial natriuretic peptide (1-28) |
分子量 | 3082.49 |
分子式 | C127H205N45O39S3 |
CAS No. | 91917-63-4 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Atrial natriuretic factor (1-28) (human, porcine) 91917-63-4 Atrial natriuretic peptide Atrial natriuretic factor (1 28) (human, porcine) Atrial natriuretic peptide (1-28) Atrial natriuretic factor (128) (human, porcine) Atrial natriuretic factor Inhibitor inhibitor inhibit